ArticleAnalytical chemistry2026
Proximity-Based Phospho-Interactome (Prob-PhI) Characterization Reveals Distinct Signaling Activities of MEK1 and MEK2.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein kinases play a key role in regulating cellular processes through protein phosphorylation. Comprehensive identification of kinase-specific substrates is essential for elucidating mechanisms of health and disease, yet remains a significant challenge. Here, we present the proximity-based phospho-interactome (Prob-PhI) platform─a novel and streamlined method for dissecting kinase interactomes and substrate profiles. Prob-PhI utilizes the rapid biotin ligase BASU to label proteins in proximity to a kinase of interest. Phosphorylation events among these biotinylated interactors are then enriched and analyzed under conditions with and without kinase inhibition, enabling the identification of differential phosphorylation and corresponding substrates. We applied Prob-PhI to MEK1 and MEK2, central components of the mitogen-activated protein kinase (MAPK) pathway, and delineated their distinct interactomes and phosphoproteomes. Notably, functional validation revealed that MEK2, but not MEK1, specifically interacts with and phosphorylates lysosome-associated membrane glycoprotein 3 (LAMP3) at threonine 201, thereby modulating lysosomal function. This study highlights the unique substrate profiles of MEK1 and MEK2 and demonstrates the applicability of Prob-PhI in mapping kinase signaling networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.